Will there be enough of the Mpox vaccine after the recent outbreak?

Available for over a year

As Sweden's confirmed the first case of the new Mpox variant outside Africa, we spoke to Paul Chaplin, of drug manufacturer Bavaria Nordic who are the main producer of the vaccine, on whether there's enough of the vaccine to fight the disease. In the US the White House says its negotiated a big cut in the prices of some key medicines. The deal was reached with big pharmaceutical companies and covers ten medicines for conditions including diabetes and heart failure. But how has the US government achieved such a deal? Rahul Tandon speaks to a health policy professor in Tennessee. And we discuss the problem's facing India's economy, where issues of women in the workplace are back in the spot light after the rape and murder of a female doctor in Kolkata. The latest business and finance news from around the world, on the BBC.